{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:03Z","timestamp":1791999483660,"version":"4.4.0"},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sickle cell disease (SCD) is a hematologic disorder defined by presence of sickle\u2010shaped red blood cells that can occlude blood vessels and cause tissue ischemia and pain. Treating SCD pain adequately and safely is difficult given today's opioid climate. Buprenorphine\u2010naloxone has been described as an alternative option to treat chronic pain in the adult literature; however, it historically required discontinuation of full\u2010agonist opioids before initiation, resulting in opioid withdrawal. Herein we present two adolescents with SCD who successfully weaned off large doses of full\u2010agonist opioids by using microdose induction of buprenorphine\u2010naloxone in clinic, without experiencing significant opioid withdrawal. Ambulatory microdose induction may remove hurdles that otherwise would discourage patients from trying this regimen while still controlling pain safely.<\/jats:p>","DOI":"10.1002\/pbc.28766","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T06:06:24Z","timestamp":1603865184000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ambulatory microdose induction of buprenorphine\u2010naloxone in two adolescent patients with sickle cell disease"],"prefix":"10.1002","volume":"68","author":[{"given":"Bradley M.","family":"Buchheit","sequence":"first","affiliation":[{"name":"Department of Family Medicine Oregon Health &amp; Science University  Portland Oregon"},{"name":"Department of Medicine Division of General Internal Medicine and Geriatrics Section of Addiction Medicine Oregon Health &amp; Science University  Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Joslin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine Oregon Health &amp; Science University  Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen N.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine Oregon Health &amp; Science University  Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-6217","authenticated-orcid":false,"given":"Trisha E.","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology and Department of Pathology Oregon Health &amp; Science University  Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM\u20105)","author":"American Psychiatric Association","year":"2014"},{"key":"e_1_2_8_3_1","unstructured":"Drug Enforcement Agency \u2010 Drug & Chemical Evaluation Section.Buprenorphine (Trade Names: Buprenex\u00ae Suboxone\u00ae Subutex\u00ae).2019."},{"key":"e_1_2_8_4_1","unstructured":"SAMHSA.Treatment Improvement Protocol (TIP) 63 \u2010 Medications for Opioid Use Disorder.2020.https:\/\/store.samhsa.gov\/sites\/default\/files\/SAMHSA_Digital_Download\/PEP20-02-01-006_508.pdf. Accessed October 20 2020."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2313"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/24740527.2019.1599279"},{"issue":"2","key":"e_1_2_8_7_1","article-title":"Case report: successful induction of buprenorphine\/naloxone using a microdosing schedule and assertive outreach","volume":"15","author":"Rozylo J","year":"2020","journal-title":"Addict Sci Clin Pract"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.74018"},{"key":"e_1_2_8_9_1","article-title":"Buprenorphine induction without opioid withdrawal: a case series of 15 opioid\u2010dependent inpatients induced on buprenorphine using microdoses of transdermal buprenorphine","author":"Raheemullah A","year":"2019","journal-title":"Am J Ther"},{"issue":"3","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamainternmed.2018.6749","article-title":"Initiating opioid agonist treatment for opioid use disorder in the inpatient setting: a teachable moment","volume":"179","author":"Raheemullah A","year":"2019","journal-title":"JAMA Intern Med"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001138"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000618"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S109919"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1261914"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.28766","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T10:37:40Z","timestamp":1693737460000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.28766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1002\/pbc.28766"],"URL":"https:\/\/doi.org\/10.1002\/pbc.28766","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"2020-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28766"}}